Literature DB >> 6846838

Automated bioluminescent assays for NADH, glucose 6-phosphate, primary bile acids, and ATP.

L J Kricka, G K Wienhausen, J E Hinkley, M De Luca.   

Abstract

An automated flow system for the bioluminescent assay of various metabolites have been developed. The enzymes used in the assays have been coimmobilized onto Sepharose and packed into small flow cells. Assays for NADH, glucose 6-phosphate, and primary bile acids utilize the bacterial NADH:FMN oxidoreductase/luciferase and either glucose-6-phosphate dehydrogenase or 7 alpha-hydroxysteroid dehydrogenase. ATP assays were performed using immobilized firefly luciferase. In general, the lower limit of detection of the metabolites was at the picomole level, and light intensity was proportional to the substrate concentration from several picomoles to several hundred picomoles. The reproducibility was good with coefficient of variations in the range of 2-5%. The carryover was less than 5% and 30 samples per hour could be assayed. The flow cells were reusable for up to 700 consecutive assays. The major factor limiting their continued use was bacterial contamination of the Sepharose. The results obtained for serum primary bile acids using the bioluminescent assay wer in good agreement with independent measurements on the same samples using gas-liquid chromatography. The immobilized firefly luciferase system was successfully used to measure high levels of bacteria in urine specimens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6846838     DOI: 10.1016/0003-2697(83)90567-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

Review 1.  Immobilized bacterial luciferase and its applications.

Authors:  N N Ugarova; O V Lebedeva
Journal:  Appl Biochem Biotechnol       Date:  1987-06       Impact factor: 2.926

2.  Epidermal growth factor stimulates glycogen synthase activity in cultured cells.

Authors:  C P Chan; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.